The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL.74, 2012, Pages

  Holton, Kathleen F ^a,c   Taren, Douglas L ^b   Thomson, Cynthia A ^c   Bennett, Robert M ^d   Jones, Kim D ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Environmental Research Laboratory   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adverse effects; Diet; Fibromyalgia; Glutamate; Irritable bowel syndrome

Indexed keywords

ASPARTAME; GLUTAMATE SODIUM; PLACEBO; GLUTAMIC ACID; NEUROTOXIN;

ABDOMINAL PAIN; ABDOMINAL SWELLING; ADULT; AGED; ARTICLE; BALANCE IMPAIRMENT; BODY TEMPERATURE DISORDER; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIET; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; ENVIRONMENTAL DISEASE; ESOPHAGUS SPASM; FEMALE; FIBROMYALGIA; FLUSHING; HEADACHE; HUMAN; IRRITABLE COLON; LUNG CONGESTION; MALE; MIGRAINE; NAUSEA; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SWEATING; SYMPTOM; TEMPOMANDIBULAR JOINT DISORDER; TREATMENT DURATION; VISUAL DISORDER; ANALYSIS OF VARIANCE; CONTROLLED CLINICAL TRIAL; DAILY LIFE ACTIVITY; DIET THERAPY; MIDDLE AGED; PAIN; PAIN ASSESSMENT; PREDICTIVE VALUE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; UNITED STATES;

ACTIVITIES OF DAILY LIVING; ADULT; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DIET; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; GLUTAMIC ACID; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; NEUROTOXINS; OREGON; PAIN; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SODIUM GLUTAMATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84860851850     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. MARCUS DA: Fibromyalgia: diagnosis and treatment options. Gend Med 2009; 6 (Suppl. 2): 139-51.
2. BENNETT R, JONES J, TURK DC, RUSSELL IJ, MATALLANA L: An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 2007; 8: 27.
3. SERRA E, SPAETH M, CARBONELL J et al.: Development of the Fibromyalgia Burden Assessment: measuring the multifaceted burden of fibromyalgia. Clin Exp Rheumatol 2010; 28 (Suppl. 63): S87-93.
4. PICCINNI A, BAZZICHI L, MARAZZITI D et al.: Subthreshold mood symptoms in patients with fibromyalgia and rheumatoid arthritis. Clin Exp Rheumatol 2011, 29 (Suppl. 69): S55-9.
5. CONVERSANO C, LENSI E, BAZZICHI L, SERNISSI F, DELL'OSSO L: How important are the psychological aspects in fibromyalgic syndrome? Clin Exp Rheumatol 2010; 28 (Suppl. 63): S3-6.
6. YUNUS MB: Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007; 36: 339-56.
7. KURLAND JE, COYLE WJ, WINKLER A, ZABLE E: Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci 2006; 51: 454-60.
8. SARCHIELLI P, DI FILIPPO M, NARDI K et al.: Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep 2007; 11: 343-51.
9. SMITH QR: Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr 2000; 130 (4S Suppl.): 1016S-22S.
10. OLNEY JW: Excitotoxicity: an overview. Can Dis Wkly Rep 1990; 16 (Suppl. 1E): 47-57; discussion 57-8.
11. OLNEY JW, HO OL, RHEE V, DEGUBAREFF T: Letter: Neurotoxic effects of glutamate. N Engl J Med 1973; 289: 1374-5.
12. OLNEY JW: Excitatory transmitter neurotoxicity. Neurobiol Aging 1994; 15: 259-60.
13. OLNEY JW: Excitotoxins in foods. Neurotoxicology 1994; 15: 535-44.
14. SMITH JD, TERPENING CM, SCHMIDT SO, GUMS JG: Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother 2001; 35: 702-6.
15. CIAPPUCCINI R, ANSEMANT T, MAILLEFERT JF, TAVERNIER C, ORNETTI P: Aspartame-induced fibromyalgia, an unusual but curable cause of chronic pain. Clin Exp Rheumatol 2010; 28 (Suppl. 63): S131-3.
16. JONES KD, REINER AC: A multistep recruitment strategy to a participant-intensive clinical trial. Appl Nurs Res 2010; 23: 227-32.
17. WOLFE F, SMYTHE HA, YUNUS MB et al.: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-72.
18. IBS Module. Available at: http://www.romecriteria.org/pdfs/IBSMode.pdf. Accessed Sept 10 2006.
19. EASTOE JE: The amino acid composition of mammalian collagen and gelatin. Biochem J 1955; 61: 589-600.
20. GEHA RS, BEISER A, REN C et al.: Multicenter, double-blind, placebo-controlled, multiple-challenge evaluation of reported reactions to monosodium glutamate. J Allergy Clin Immunol 2000; 106: 973-80.
21. GEHA RS, BEISER A, REN C et al.: Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study. J Nutr 2000; 130 (4S Suppl.): 1058S-62S.
22. YANG WH, DROUIN MA, HERBERT M, MAO Y, KARSH J: The monosodium glutamate symptom complex: assessment in a doubleblind, placebo-controlled, randomized study. J Allergy Clin Immunol 1997; 99: 757-62.
23. BENNETT RM, FRIEND R, JONES KD, WARD R, HAN BK, ROSS RL: The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 2009; 11: R120.
24. DROSSMAN DA, PATRICK DL, WHITEHEAD WE et al.: Further validation of the IBSQOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000; 95: 999-1007.
25. GRIZZLE JE: The Two-Period Change-over Design an Its Use in Clinical Trials. Biometrics 1965; 21: 467-80.
26. WALLENSTEIN S, FISHER AC: The analysis of the two-period repeated measurements crossover design with application to clinical trials. Biometrics 1977; 33: 261-9.
27. AZAD KA, ALAM MN, HAQ SA et al.: Vegetarian diet in the treatment of fibromyalgia. Bangladesh Med Res Counc Bull 2000; 26: 41-7.
28. HANNINEN, KAARTINEN K, RAUMA AL et al.: Antioxidants in vegan diet and rheumatic disorders. Toxicology 2000; 155: 45-53.
29. KAARTINEN K, LAMMI K, HYPEN M, NENONEN M, HANNINEN O, RAUMA AL: Vegan diet alleviates fibromyalgia symptoms. Scand J Rheumatol 2000; 29: 308-13.
30. DONALDSON MS, SPEIGHT N, LOOMIS S: Fibromyalgia syndrome improved using a mostly raw vegetarian diet: an observational study. BMC Complement Altern Med 2001; 1: 7.
31. MICHALSEN A, RIEGERT M, LUDTKE R et al.: Mediterranean diet or extended fasting's influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid arthritis and fibromyalgia: an observational study. BMC Complement Altern Med 2005; 5: 22.
32. HOLTON KF, KINDLER LL, JONES KD: PotenS-17 tial dietary links to central sensitization in fibromyalgia: past reports and future directions. Rheum Dis Clin North Am 2009; 35: 409-20.
33. BAZZICHI L, PALEGO L, GIANNACCINI G et al.: Altered amino acid homeostasis in subjects affected by fibromyalgia. Clin Biochem 2009; 42: 1064-70.
34. LARSON AA, GIOVENGO SL, RUSSELL IJ, MICHALEK JE: Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 2000; 87: 201-11.
35. PERES MF, ZUKERMAN E, SENNE SOARES CA et al.: Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia 2004; 24: 735-9.
36. HARRIS RE, SUNDGREN PC, PANG Y et al.: Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 2008; 58: 903-7.
37. HARRIS RE, SUNDGREN PC, CRAIG AD et al.: Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 2009; 60: 3146-52.
38. FAYED N, GARCIA-CAMPAYO J, MAGALLON R et al.: Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate. Arthritis Res Ther 2010; 12: R134.
39. VALDES M, COLLADO A, BARGALLO N et al.: Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study. Arthritis Rheum 2010; 62: 1829-36.
40. AFONSO PV, OZDEN S, PREVOST MC et al.: Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J Immunol 2007; 179: 2576-83.
41. ROBINSON JS, MOODY RA: Influence of respiratory stress and hypertension upon the blood-brain barrier. J Neurosurg 1980; 53: 666-73.
42. BELOVA I, JONSSON G: Blood-brain barrier permeability and immobilization stress. Acta Physiol Scand 1982; 116: 21-9.
43. BARZO P, MARMAROU A, FATOUROS P, CORWIN F, DUNBAR J: Magnetic resonance imaging-monitored acute blood-brain barrier changes in experimental traumatic brain injury. J Neurosurg 1996; 85: 1113-21.
44. LATREMOLIERE A, WOOLF CJ: Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009; 10: 895-926.
45. BLAYLOCK RL: Excitotoxins. The Taste that Kills. Santa Fe, New Mexico: Health Press; 1997.